Analysis of menopause and application of hormone therapy as therapeutic management
DOI:
https://doi.org/10.51326/ec.7.9944072Keywords:
Climacteric, Menopause, Hormone Replacement TherapyAbstract
Introduction: Menopause is not a disease, but rather a natural stage in a woman's life. During this period, several physiological changes occur that affect quality of life. Therefore, Hormone Replacement Therapy is considered the first-line treatment.
Objective: To analyze the menopausal period and the effectiveness of the application of hormonal therapy as therapeutic management.
Methodology: For this research, a literature review, selection of scientific articles and application of the PRISMA method was carried out.
Results: 14 publications were obtained according to the inclusion, exclusion and keywords criteria for review.
Discussion: Most women present vasomotor symptoms that affect their quality of life, therefore, hormone replacement therapy is the way to compensate for estrogen deficiency. Thanks to important studies carried out in recent decades, a controversy over the benefits and risks has subsided. potentials.
Conclusions: Hormonal Therapy is safe in healthy women in the early menopausal period, corroborating that the treatment does reduce symptoms. The treatment is fully recommended for patients where their quality of life is being significantly affected.
Downloads
References
Guerrero Hines C, Chacón Camos NV, Pizarro Madrigal M. Actualización de menopausia y terapia de reemplazo hormonal. Rev Med Sinerg. 2023;8(1):e933. https//doi.org/10.31434/rms.v8i1.933
Shufelt CL, Manson JE.. Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery. J Clin Endocrinol Metab. 2021;106(5):1245-54. https//doi.org/10.1210/clinem/dgab042
Dois A, Urrutia MT, Araya AX. El significado de la menopausia para un grupo de mujeres chilenas atendidas en el sistema público de salud. Rev Med Chile. 2022;150(1):62-9. https//doi.org/10.4067/S0034-98872022000100062
Yefimenko O. Menopauseal hormonal therapy and the risk of breast cancer in the light of new data: Literature review. Reprod Endocrinol. 2022;(66):77-80. https://doi.org/10.18370/2309-4117.2022.66.77-80
Pereira Rodriguez JE, Peñaranda Flórez DG, Barreto Castillo LL, Arrieta Mercado MA, Pereira Rodríguez P, Meza Vivanco I. Respuesta cardiovascular y frecuencia cardiaca máxima en mujeres con menopausia. 2020;18(1):88-95. Disponible en: https://medisur.sld.cu/index.php/medisur/article/view/4320 [Consultado 01-06-2023]
English M, Stoykova B, Slota C, Doward L, Siddiqui E, Crawford R, et al. Qualitative study: burden of menopause-associated vasomotor symptoms (VMS) and validation of PROMIS Sleep Disturbance and Sleep-Related Impairment measures for assessment of VMS impact on sleep. J Patient-Rep Outcomes. 2021;5(1):37. https://doi.org/10.1186/s41687-021-00289-y
Scavello I, Maseroli E, Di Stasi V, Vignozzi L. Sexual Health in Menopause. Medicina (Kaunas). 2019;55(9):559. https://doi.org/10.3390/medicina55090559
Kohn GE, Rodriguez KM, Hotaling J, Pastuszak AW. The History of Estrogen Therapy. Sex Med Rev. 2019;7(3):416-21. https://doi.org/10.1016/j.sxmr.2019.03.006
Ayala Peralta FD. Estrategias de manejo durante el climaterio y menopausia. Guía práctica de atención rápida. Rev Peru Investig Matern Perinat. 2020;9(2):34-41. https://doi.org/10.33421/inmp.2020204
Oliver-Williams C, Glisic M, Shahzad S, Brown E, Pellegrino Baena C, Chadni M, et al. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Hum Reprod Update. 2019;25(2):257-71. https://doi.org/10.1093/humupd/dmy039
Villanea C. Terapia de reemplazo hormonal: ventana de oportunidad. Rev Medica Sinerg. 2019;4(1):14-22. Disponible en: https://doi.org/10.31434/rms.v4i1.166
Roldán G, Tabares G. Síntomas vasomotores en la menopausia: una mirada a la fisiología. 2020;26(2):7-15. https://docs.bvsalud.org/biblioref/2021/06/1254059/26_2-8-16.pdf [Consultado 01-06-2023]
Duarte Jeremías M, Vargas Chaves S. Tratamiento local del síndrome genitourinario en la menopausia. Rev Medica Sinerg. 2020;5(9):e570. https://doi.org/10.31434/rms.v5i9.570
Hodis HN, Mack WJ. Menopausal Hormone Replacement Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease: It Is About Time and Timing. Cancer J. 2022;28(3):208-23. https://doi.org/10.1097/PPO.0000000000000591
Kagan R, Kellogg-Spadt S, Parish SJ. Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause. Drugs Aging. 2019;36(10):897-908. https://doi.org/10.1007/s40266-019-00700-w
Jin J. Treatment of Menopause Symptoms With Hormone Therapy. JAMA. 2022;327(17):1716. https://doi.org/10.1001/jama.2022.5105
Yoon SH, Lee JY, Lee C, Lee H, Kim SN. Gabapentin for the treatment of hot flushes in menopause: a meta-analysis. Menopause. 2020;27(4):485-93. Disponible en: https://doi.org/10.1097/GME.0000000000001491
Deli T, Orosz M, Jakab A. Hormone Replacement Therapy in Cancer Survivors – Review of the Literature. Pathol Oncol Res. 2020;26(1):63-78. https://doi.org/10.1007/s12253-018-00569-x
Cagnacci A, Venier M. The Controversial History of Hormone Replacement Therapy. Medicina (Kaunas). 2019;55(9):602. http://doi.org/10.3390/medicina55090602
Mei Y, Williams JS, Webb EK, Shea AK, MacDonald MJ, Al-Khazraji BK. Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative Review. Front Rehabil Sci. 2022;3:825147. https://doi.org/10.3389/fresc.2022.825147
Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA. 2020;324(4):369. https://doi.org/10.1001/jama.2020.9482
Flores VA, Pal L, Manson JE. Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Endocr Rev. 2021;42(6):720-52. https://doi.org/10.1210/endrev/bnab011
Gosset A, Pouillès JM, Trémollieres F. Menopausal hormone therapy for the management of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101551. https://doi.org/10.1016/j.beem.2021.101551
Espitia De La Hoz FJ. Efectividad de la tibolona e incidencia de efectos adversos en mujeres posmenopáusicas. Estudio cuasiexperimental en Armenia (Colombia), 2012-2015. Univ Médica. 2021;62(4). Disponible en: https://revistas.javeriana.edu.co/index.php/vnimedica/article/view/33416 [Consultado 03-06-2023]
Ayenew A, Yechale M, Nigussie A, Ayalew N. Women’s Knowledge of Concept of Menopause, Severity, and Climacteric Stage Among Women in Middle Age in Northwest Ethiopia: Community-Based Cross-Sectional Study. 2021. https://doi.org/10.21203/rs.3.rs-638981/v1
Kaunitz AM, Pinkerton J. 2022 Update on menopause. OBG Manag. 2022;34(7):16-19,24-25,32,49-50. https://doi.org/10.12788/obgm.0210
Kim YJ, Soto M, Branigan GL, Rodgers K, Brinton RD. Association between menopausal hormone therapy and risk of neurodegenerative diseases: Implications for precision hormone therapy. Alzheimer's Dement. 2021;7:e12174. https://doi.org/10.3390/nu12010202
Stute P, Wienges J, Koller AS, Giese C, Wesemüller W, Janka H, et al. Cognitive health after menopause: Does menopausal hormone therapy affect it? Best Pract Res Clin Endocrinol Metab. 2021;35(6):101565. https://doi.org/10.1016/j.beem.2021.101565
Nash Z, Al-Wattar BH, Davies M. Bone and heart health in menopause. Best Pract Res Clin Obstet Gynaecol. 2022;81:61-8. https://doi.org/10.1016/j.bpobgyn.2022.03.002
Kalra B, Kalra S, Bhattacharya S, Dhingra A. Menopause distress: A person centered definition. J Pak Med Assoc. 2020;70(12(B)):2481-3. Disponible en: https://jpma.org.pk/PdfDownload/10288 [Consultado 07-06-2023]
Pan M, Pan X, Zhou J, Wang J, Qi Q, Wang L. Update on hormone therapy for the management of postmenopausal women. Biosci Trends. 2022;16(1):46-57. https://doi.org/10.5582/bst.2021.01418
Graham S, Archer DF, Simon JA, Ohleth KM, Bernick B. Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins. Gynecol Endocrinol. 2022;38(11):891-910. https://doi.org/10.1080/09513590.2022.2118254
Hamoda H, Moger S, Morris E, Baldeweg S, Kasliwal A, Gabbay F, et al. Menopause practice standards. Post Reprod Health. 2022;28(3):127-32. https://doi.org/10.1111/cen.14789
Hidalgo L, Saldías-Fuentes C, Carrasco K, Halpern AC, Mao JJ, Navarrete-Dechent C. Complementary and alternative therapies in skin cancer a literature review of biologically active compounds. Dermatol Ther. 2022;35(11):e15842. https://doi.org/10.1111/dth.15842
Valdes A, Bajaj T. Estrogen Therapy. En: StatPearls. Treasure Island (FL): StatPearls; 2023. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK541051/ [Consultado 07-06-2023]
Silva T, Oppermann K, Reis F, Spritzer P. Nutrition in Menopausal Women: A Narrative Review. Nutrients. 2021;13(7):2149. https://doi.org/10.3390/nu13072149
Dąbrowska-Galas M, Dąbrowska J, Ptaszkowski K, Plinta R. High Physical Activity Level May Reduce Menopausal Symptoms. Medicina (Kaunas). 2019;55(8):466. https://doi.org/10.3390/medicina55080466
Dunneram Y, Greenwood DC, Cade JE. Diet, menopause and the risk of ovarian, endometrial and breast cancer. Proc Nutr Soc. 2019;78(3):438-48. https://doi.org/10.1017/s002966511800288
